Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.536,75
-0,50%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Affimed NV (AFMD) Affimed NV (AFMD) Notizie

Affimed NV

AFMD
2,75
0,11 (4,17%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202412:30GLOBEAffimed Reports Third Quarter 2024 Financial Results &..
12/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/11/202423:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/11/202412:30GLOBEAffimed to Report Third Quarter 2024 Financial Results &..
05/11/202415:00GLOBEAffimed Announces Acceptance of Three Abstracts at the 2024..
04/11/202419:08EDGAR2Form F-3 - Registration statement by foreign private issuers
15/10/202412:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202413:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/9/202412:30GLOBEAffimed to Present at the Cantor Global Healthcare..
05/9/202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202412:30GLOBEAffimed Reports Second Quarter 2024 Financial Results &..
03/9/202414:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/9/202413:45GLOBEAffimed Appoints Shawn M. Leland as Chief Executive Officer
29/8/202412:30GLOBEAffimed to Report Second Quarter 2024 Financial Results..
12/6/202413:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/6/202413:13IHMARKETNEWSU.S. Futures Rise on Fed Decision; Oil Gains on Demand..
12/6/202412:30GLOBEAffimed Reports First Quarter 2024 Financial Results &..
06/6/202423:13EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
05/6/202412:30GLOBEAffimed to Report First Quarter 2024 Financial Results &..
03/6/202412:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/6/202419:02GLOBEAffimed Provides Follow-up Data of AFM24 plus Atezolizumab..
29/5/202412:30GLOBEAffimed Receives Fast Track Designation for Combination..
28/5/202412:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202412:30GLOBEAffimed Announces Annual General Meeting of Shareholders
23/5/202423:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202423:05GLOBEAffimed Announces Positive Early Efficacy and Progression..
14/5/202416:05GLOBEAffimed Announces Acceptance of an Abstract on Preclinical..
24/4/202410:05GLOBEAffimed Announces Acceptance of AFM24 Clinical Abstract at..
28/3/202411:30GLOBEAffimed Reports 2023 Financial Results and Operational..
21/3/202411:30GLOBEAffimed To Report Full Year 2023 Financial Results &..
11/3/202421:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/3/202412:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/3/202412:30GLOBEAffimed Announces 1-for-10 Reverse Stock Split
08/1/202422:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202422:05GLOBEAffimed Provides Clinical Response Update on AFM24-102 Trial..
08/1/202414:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202414:00GLOBEAffimed Announces Leadership Change and Organizational..
03/1/202412:30GLOBEAffimed Announces Sale of Wholly-Owned Subsidiary AbCheck
11/12/202312:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202312:02GLOBEAffimed Announces Positive Data for AFM24 in Combination..
11/12/202312:00GLOBEAffimed Announces Updated Phase 1/2 Data from Acimtamig in..
04/12/202312:30GLOBEAffimed to Host Investor Conference Call Highlighting..
30/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 2,64 Min: 2,61 Max: 2,755
Chiusura: 2,64

La tua Cronologia

NASDAQ
AFMD
Affimed NV
FTSE
UB6510
FTSE 350 Utilities
DOWI
W2CYC
DJ Global exUS Consumer ...
BOV
OIBR3
OI ON
BITI
IT4000
Ftse Italia Salute
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network